|
The contributions of age related changes in the sound localization pathway to central hearing loss
Do you think you have good hearing? Are you between the age of 40 and 89? If so, you may be eligible to participate in a research study on the effects on hearing. If your hearing qualifies, you will complete a series of listening and hearing assessments and questionnaires over the co... Protocol #: 19-1213 Location: CU Anschutz non-hospital research facilities |
|
A 16-Week Randomized, Double-Blind, Placebo Controlled, Parallel-Group,
Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 ig Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps followed by a 12-Week Open-Label Treatment Phase
Protocol #: 18-1445 Location: Childrens Hospital Colorado |
|
Using Oscillometry in Toddler Aerodigestive Patients to Monitor Lung Function Response to Treatment
In this study, we will 1. Assess different mouthpiece options to help make the test easier to do in young children 2. Obtain AOS measurements in children who are patients in the aerodigestive clinic at Children's Hospital Colorado 3. Compare these measurements to those obtained in chil... Protocol #: 21-2637 Location: Childrens Hospital Colorado |
|
Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers
We are studying how asthma develops in early childhood to help doctors provide better asthma treatments for children. If you decide to participate, your child will complete up to five research visits. There will be one visit per year over 4 years. During the visits your child will d... Protocol #: 21-3116 Location: Childrens Hospital Colorado |
|
Genetic and epigenomic determinants of hearing loss in Hispanic populations
This study aims to identify genes and variants that are related to sensorineural hearing loss (SNHL) in children, including Hispanic children from multiple recruitment sites and non-Hispanic children from Colorado who are diagnosed with severe-to-profound congenital SNHL. We will collect D... Protocol #: 21-3609 Location: Boulder Health Center, Childrens Hospital Colorado |
|
A randomised, double-blind, parallel group Phase III study to assess the
efficacy and safety of 100 mg SC depemokimab in patients with chronic rhinosinusitis
with nasal polyps (CRSwNP) - ANCHOR-1 (depemokimAb iN CHrOnic Rhinosinusitis)
If you choose to participate, you will have 17 visits for a little over 1 year. Most visits will be about 4 weeks apart; some will be 2 weeks apart. Visits are typically about 2 hours long, but the first visit, two injection visits, and the second to last visit will take about 6 hours. The... Protocol #: 22-1480 Location: Anschutz Health and Wellness, University of Colorado Hospital |